Results 91 to 100 of about 137,068 (205)

The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review

Терапевтический архив
In September 2023, the European Association for the Study of the Liver (EASL) updated the disease nomenclature for non-alcoholic (metabolically associated) fatty liver disease.
Chavdar S. Pavlov, Daria A. Teplyuk, Leonid B. Lazebnik, Aleksandr S. Ametov, Evgeniia Yu. Pashkova, Sergey M. Sorokoletov, Yury P. Uspenskiy, Svetlana V. Turkina, Elizaveta V. Ponomarenko, Aleksandr S. Maslakov   +9 more
doaj   +1 more source

Lipoxin-A4 in the rabbit model of atherosclerosis and liver steatosis [PDF]

, 2019
BACKGROUND: Obesity is a global health problem that is associated with wide range of diseases, including atherosclerosis and Nonalcoholic fatty liver (NAFL) disease.
Singh, Jaskamal Kaur
core  

Influence of antidysbiotic drugs on the liver of rats with experimental non-alcoholic steatohepatitis

Journal of Education, Health and Sport, 2017
High-fat diets combined with the introduction of lincomycin causes the development of steatohepatitis. Introduction antidysbiotic drugs (pro- and prebiotics) has a therapeutic effect.
A. P. Levitsky, V. L. Vasjuk, E. M. Levchenko   +2 more
doaj  

Gallic acid mitigates high-fat and high-carbohydrate diet-induced steatohepatitis by modulating the IRF6/PPARγ signaling pathway

Frontiers in Pharmacology
Gallic acid (GA), a natural organic phenolic compound, is an abundant plant food bioactive substance present in many medicinal herbs. GA has anti-oxidative, anti-inflammatory and anticancer activities on multiple metabolic disorders.
Jiahao Qiu, Jiahao Qiu, Lihong Fu, Yan Xue, Yan Xue, Yilan Yang, Fengjie Qiao, Wanchun Zhu, Yating Gao, Miao Fang, Yufei Liu, Zhujun Gao, Yunfeng Guan, Yunfeng Guan, Yueqiu Gao, Yueqiu Gao, Yueqiu Gao, Xin Zhang, Zhi Shang, Zhi Shang, Zhi Shang   +20 more
doaj   +1 more source

Alcoholic liver disease: State-of-the-art

Терапевтический архив, 2014
The literature review gives the present views of the diagnosis and treatment of alcoholic liver disease (ALD) and data on the genetic markers associated with the development of ALD and alcohol addiction.
I V Maev, D T Abdurakhmanov, D N Andreev, D T Dicheva   +3 more
doaj  

Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis

Frontiers in Endocrinology
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by impaired ...
Bruno Ramos-Molina, Joana Rossell, Joana Rossell, Alejandra Pérez-Montes de Oca, Eva Pardina, Idoia Genua, Marina I. Rojo-López, María Teresa Julián, Núria Alonso, Núria Alonso, Josep Julve, Josep Julve, Didac Mauricio, Didac Mauricio, Didac Mauricio, Didac Mauricio, Didac Mauricio   +16 more
doaj   +1 more source

Obesity dependent metabolic signatures associated with nonalcoholic fatty liver disease progression [PDF]

, 2012
Our understanding of the mechanisms by which nonalcoholic fatty liver disease (NAFLD) progresses from simple steatosis to steatohepatitis (NASH) is still very limited.
Alonso, C, Barr, J, Caballería, J, Domínguez-Díez, A, Martínez Arranz, Ibon, Moto, J.M., Muntané Relat, Jordi, Romero Gómez, Manuel   +7 more
core  

Sex-specific effects of peptidyl arginine deiminase 4 deficiency in the cafeteria diet-induced obesity-associated metabolic complications

Frontiers in Endocrinology
BackgroundObesity is a global health challenge linked to chronic non-communicable diseases. Low-grade inflammation and altered immune responses, including neutrophil extracellular trap (NET) formation, contribute to metabolic complications.
Andrej Feješ, Emil Bečka, Ivana Feješ Slivková, Kristína Macáková, Emőke Šteňová, Michal Pastorek, Peter Celec, Roman Gardlík, Katarína Šebeková, Veronika Borbélyová   +9 more
doaj   +1 more source

Plasma Extracellular Vesicles Contain Protein Biomarkers for Capturing Stages of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Preliminary Exploratory Study

Biomolecules
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing in both prevalence and severity, highlighting the need for non-invasive biomarkers to assess disease activity.
Yakun Li, Koen C. van Son, Sandra Serna-Salas, Justina C. Wolters, Nienke P. M. Wassenaar, Stan Driessen, Anne Linde Mak, Anne-Marieke van Dijk, Veera A. T. Houttu, Julia J. Witjes, Diona Zwirs, Michail Doukas, Joanne Verheij, Robin P. F. Dullaart, Hans Blokzijl, Adriaan G. Holleboom, Han Moshage   +16 more
doaj   +1 more source

hs-CRP as a Marker of Systemic Low-Grade Inflammation Is Not Associated with Steatotic Liver Disease in Adolescents: Insights from the EVA4YOU Study

Metabolites
Objectives: Systemic low-grade inflammation is associated with steatohepatitis in adults. We aim to explore if systemic low-grade inflammation, measured by plasma high-sensitivity C-reactive protein (hs-CRP), is also linked to steatotic liver disease in ...
Johannes Nairz, Alex Messner, Sophia Zollner-Kiechl, Ursula Kiechl-Kohlendorfer, Michael Knoflach   +4 more
doaj   +1 more source